Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alzamend Neuro, Inc. Director's Dealing 2021

Sep 3, 2021

35321_dirs_2021-09-03_e69a9333-182d-4136-9786-6339f8bf58ec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alzamend Neuro, Inc. (ALZN)
CIK: 0001677077
Period of Report: 2021-09-03

Reporting Person: AULT MILTON C III (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-03 Common Stock M 150000 Acquired 150000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-03 Stock Options (Right to Buy) $0.0004 M 150000 Disposed 2026-04-29 Common Stock (150000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6715388 Indirect
Common Stock 15000000 Indirect
Common Stock 10000000 Indirect

Footnotes

F1: This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.

F2: Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.

F3: Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.

F4: Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.

F5: The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.